Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
95% of athletes are diagnosed and treated for non-invasive heart disease, such as heart attacks or seizures, or implantable cardioverter defibrillator (ICD) shock.
Read Full NewsRifabutin-based triple regimen is noninferior to classical bismuth quadruple regimen as rescue treatment for Helicobacter pylori infection.
Hematology advanced nurse practitioners receive high satisfaction scores from clinicians and patients, although room for improvement remains regarding role clarity, a study reports.
Digital FDG PET/CT can pick up cranial giant cell arteritis that may be missed on ultrasound because of a lack of trunk large-vessel involvement.
Urinary tract infection during pregnancy is linked to an increased risk for preterm birth, with the risk being highest in the first week of diagnosis and particularly before 28 weeks of gestation.
A unique six-decade study shows that higher prenatal and early postnatal lead exposure is tied to cognitive performance in older adulthood.
NICE recommends epcoritamab for relapsed follicular lymphoma, offering a new option after multiple lines of therapy.
Rates of the side effect appear to be increasing, but it’s not yet clear why.
1.
New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show
2.
Train Eyes so Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke
3.
'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested
4.
Study offers clearer picture of childhood brain tumor survival
5.
Antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer
1.
Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches
2.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
3.
Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms
4.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
2.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
3.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
4.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
5.
Navigating the Complexities of Ph Negative ALL - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge